Business Constraints Caused by COVID-19
First written in FY2022. 3 of 6 entries say "Restated". Latest entry: FY2024.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
- FY2024ReframedAnnual report
「In response to COVID-19, the company gives top priority to the safety of business partners, related parties and employees and is working to prevent infection by establishing a telework framework and promoting the use of tools such as web conferencing systems. However, if a new infectious disease or epidemic occurs in the future, the company may face various constraints in carrying out its business,」
The scope of the disclosure has been expanded from the company's previous response to COVID-19 to the risk of business constraints from new infectious diseases and epidemics in general. - FY2024-Q2MitigatedAnnual report
「Economic activity gradually moved toward normalization and entered a moderate recovery trend as a result of the transition in May of the previous year of COVID-19 to Category 5 under the Infectious Diseases Control Law.」
The company explains that economic activity moved toward normalization following the transition of COVID-19 to Category 5, indicating that the previous business constraints are easing. - FY2023RestatedAnnual report
「In response to COVID-19, the company gives top priority to the safety of business partners, related parties and employees and is working to prevent infection by establishing a remote-work framework, promoting the use of tools such as web conferencing systems, and encouraging the use of alcohol-based disinfectant when employees come to the office.」
The company continues to address the risk of business constraints caused by infectious diseases through remote work, web conferences, disinfection and other measures. - FY2023-Q3RestatedAnnual report
「At the same time, the prolonged COVID-19 pandemic and stagnation in corporate activity caused by supply chain disruptions have directly affected manufacturing operations, and the operating environment remains difficult.」
The company continues to describe constraints on corporate activity caused by COVID-19 and supply chain disruptions. - FY2023-Q1RestatedAnnual report
「The company expects demand for its business-matching business to expand as investment in open innovation grows, including investment in the creation of new technologies through corporate research spending, the resumption of capital investment centered on the manufacturing sector, and efforts by regional financial institutions to diversify their revenue sources. At the same time, the prolonged COVID-19 pandemic and stagnation in corporate activity caused by supply chain disruptions have directly affected manufacturing operations, and the operating environment remains difficult.」
The impact of COVID-19 and constraints on corporate activity continue. The company states that there have been no material changes to its business and other risks. - FY2022First statedAnnual report
「As the impact of COVID-19 continued for an extended period, economic activity showed signs of recovering with the implementation of various policies and the broader rollout of vaccinations, but」
The company experienced impacts including project postponements and cancellations and has responded through remote work, web conferences and restrictions on large-scale events.